Company
Technology
Pipeline
Patents
Privacy Policy
Contact
Menu

Nothing Found

Sorry, no posts matched your criteria

Tolerogenics S.à.r.l.

Tolerogenics is developing novel immunotherapies for allergy & autoimmune diseases based on induction of tolerance. The company is a private-public-partnership with the Luxembourg Institute of Health (LIH).

Investment opportunity

Tolerogenics S.à.r.l. is offering several investment opportunities in the field of novel allergen- or autoantigen-specific immunotherapies.

Contact us for more information.

Contact

29, Rue Henri Koch
L-4354 Esch-sur-Alzette
Luxembourg

contact@tolerogenics.lu

Scroll to top

We use cookies to ensure that we give you the best experienve on our website. If you continue to use this site we will assume that you accept this.I accept cookies More Information on our Privacy Policy page